Risk Factors Predicting Vasopressor Use After Patent Ductus Arteriosus Ligation
06 October 2003 (online)
Ligation of the patent ductus arteriosus (PDA) is sometimes complicated by postoperative hypotension requiring vasopressor(s). It is unclear which infants are at risk for this complication. We conducted a retrospective and prospective cohort study to identify risk factors predicting vasopressor use after PDA ligation. Our patients were infants < 37 weeks of gestation who underwent PDA ligation. The primary outcome was the use of vasopressor(s) within 72 hours after PDA ligation, defined as beginning vasopressor(s) or increasing the dose of vasopressor(s). Thirty-two of 100 (32%) study infants required vasopressor(s) after PDA ligation. Infants who had lower birth weights, lower gestational ages, higher ventilator support, or whose mothers had received antenatal steroids had a higher risk of vasopressor use. Infants who required vasopressor(s) were at increased risk of dying before 36 weeks postmenstrual age. Lower birth weight, lower gestational age, and higher respiratory support define a high-risk subgroup of patients in whom the prophylactic administration of vasopressor(s) could be studied.
Patent ductus arteriosus (PDA) - hypotension - vasopressor
- 1 Kimball T R, Ralston M A, Khoury P, Crump R G, Cho F S, Reuter J H. Effect of ligation of patent ductus arteriosus on left ventricular performance and its determinants in premature neonates. J Am Coll Cardiol . 1996; 27 193-197
- 2 Taylor A F, Morrow W R, Lally K P, Kinsella J P, Gerstmann D R, Delemos R A. Left ventricular dysfunction following ligation of the ductus arteriosus in the preterm baboon. J Surg Res . 1990; 48 590-596.
- 3 Papile L A, Krause-Steinrauf H, Wright L L. et al . Identification of very low birth weight infants (VLBW) risk for chronic lung disease (CLD). Pediatr Res . 1994; 35 246A
- 4 Takahashi Y, Harada K, Tamura M, Takada G. Left ventricular preload reserve in preterm infants with patent ductus arteriosus. Arch Dis Child . 1994; 71 F118-F21.
- 5 Takahashi Y, Harada K, Ishida A, Tamura M, Tanaka T, Takada G. Changes in left ventricular volume and systolic function before and after the closure of ductus arteriosus in full-term infants. Early Hum Dev . 1996; 44 77-85
- 6 Crowley P. Prophylactic corticosteroids for preterm birth (Cochrane Review). In: The Cochrane Library, Issue 2 Oxford: Update Software 2001
- 7 Karlsson R, Kallio J, Scheinin M, Kero P. Antenatal and early postnatal dexamethasone treatment decreases cortisol secretion in preterm infants. Horm Res . 2000; 53 170-176
- 8 Ng P C, Wong G W, Lam C W. et al . Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants. Arch Dis Child Fetal Neonatal Ed . 1999; 80 F213-F216
- 9 Halliday H L, Ehrenkranz R A. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 2 Oxford: Update Software 2001
- 10 Yunis K A, Bitar F F, Hayek P, Mroueh S M, Mikati M. Transient hypertrophic cardiomyopathy in the newborn following multiple doses of antenatal corticosteroids. Am J Perinatol . 1999; 16 17-21
- 11 Zaugg M, Jamali N Z, Lucchinetti E. et al . Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. J Cell Physiol . 2001; 187 90-95